The Nifty Midcap Select index has reached a record high of 14,223.90, reflecting a 2% increase during Wednesday's intra-day trading on the National Stock Exchange (NSE). This achievement follows a robust 13% rise over the past month, significantly outperforming the Nifty 50 index, which increased by just 5%. The surge is largely attributed to strong performances from pharmaceutical and financial stocks, with SRF and Yes Bank leading the charge with gains of 8% and 7% respectively. The overall recovery in the equity market is supported by resilient domestic economic indicators, including a rise in India's Manufacturing Purchasing Managers' Index (PMI) to 54.7, signaling growth in new business and production. Despite ongoing global volatility, particularly due to fluctuating crude oil prices and geopolitical tensions, analysts from ICICI Prudential Asset Management Company remain optimistic about the Indian equities market, citing stable fundamentals and regulatory support. They caution, however, that the ongoing Iran-US conflict could disrupt global oil supplies, potentially impacting market conditions. Additionally, the recent assembly elections in key states may shift market focus towards earnings and geopolitical factors, with expectations of a stable earnings season ahead.